Hims & Hers won’t sell compounded version of Novo’s obesity pill
Hims & Hers said Saturday it will stop selling what it claims to be a cheaper, compounded version…
Novo Nordisk says Hims & Hers’ cheaper version of Wegovy pill is illegal
In an unexpected move, Hims & Hers is making available a cheaper, compounded version of the Wegovy weight…
Some patients experience mental health backlash from GLP-1 medications
The use of GLP-1 weight loss medications is skyrocketing in the United States, more than doubling since 2024.…
75 Hard viral fitness challenge sparks expert warnings about sustainability
NEWYou can now listen to Fox News articles! An extreme, all-or-nothing fitness regimen is going viral again as…
Quitting Ozempic Is a Risky Proposition – Newser
Quitting Ozempic Is a Risky Proposition NewserHere’s What Happens When You Stop Taking Ozempic and Wegovy – WSJ The Wall…
The rise of GLP-1 prescription drugs
QUINCY (WGEM) – How Americans spend their dollars can depend on lifestyle, priorities, or even the number of…
The share of Americans medically obese is projected to rise to almost 50% by 2035
On Wednesday, a new study published in JAMA by researchers at the University of Washington in Seattle projected…
Expert guide to all the types of GLP-1 drugs available in 2026
Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word…
US FDA Approves First Daily Oral GLP‑1 Treatment for Weight Management, Showing Comparable Results to Injectable Therapy
The US Food and Drug Administration (FDA) has approved Novo Nordisk’s new once-daily pill for weight management, designed…
Alison Hammond’s 11 stone weight loss secret revealed after one ‘drastic’ change
Alison Hammond looks incredible after undergoing a serious fitness journey in recent yearsNicola Croal Trends, Showbiz and Lifestyle…
Roche moves obesity drug to pivotal trials after mid-stage success
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q4 Results?
Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…